The growing emphasis on personalized medicine and proactive risk management is driving a significant expansion in genomic screening. The Hereditary Cancer Testing Market was valued at USD 7.04 billion in 2024 and is projected to reach USD 18.85 billion by 2032, growing at a CAGR of 20.87% during the forecast period of 2025 to 2032. This growth is fueled by the...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek